Skip to main content
Article
Usefulness of Von Willebrand Factor Activity Indexes to Predict Therapeutic Response in Hypertrophic Cardiomyopathy.
American Journal of Cardiology (2016)
  • Joseph L. Blackshear, Mayo Clinic
  • Hana Kusumoto, University of Florida
  • Robert E. Safford, Mayo Clinic
  • Ewa Wysokinska, Willmar Cancer Center, Willmar, Minnesota
  • Colleen S. Thomas, Mayo Clinic
  • Oral A. Waldo, Mayo Clinic
  • Mark E. Stark, Mayo Clinic
  • Brian P. Shapiro, Mayo Clinic
  • Steven Ung, Mayo Clinic
  • Issam Moussa, First Coast Cardiovascular, Jacksonville, Florida
  • Richard C. Agnew, Mayo Clinic
  • Kevin Landolfo, Mayo Clinic
  • Dong Chen, Mayo Clinic
Publication Date
February 1, 2016
DOI
10.1016/J.AMJCARD.2015.11.016
Citation Information
Joseph L. Blackshear, Hana Kusumoto, Robert E. Safford, Ewa Wysokinska, et al.. "Usefulness of Von Willebrand Factor Activity Indexes to Predict Therapeutic Response in Hypertrophic Cardiomyopathy." American Journal of Cardiology Vol. 117 Iss. 3 (2016) p. 436 - 442
Available at: http://works.bepress.com/oral-waldo/4/